Meeder Asset Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-50
Closed -$3K 2632
2020
Q1
$3K Sell
50
-22
-31% -$2.3K ﹤0.01% 2027
2019
Q4
$6K Sell
72
-312
-81% -$21.9K ﹤0.01% 1754
2019
Q3
$33K Buy
384
+34
+10% +$3.63K ﹤0.01% 1154
2019
Q2
$45K Buy
350
+154
+79% +$22.2K ﹤0.01% 982
2019
Q1
$34K Buy
196
+134
+216% +$19.4K ﹤0.01% 957
2018
Q4
$7K Buy
+62
New +$8.08K ﹤0.01% 1348

Other funds holding SRGA

Meeder Asset Management's SRGA Position: Q2 2020 in Review

Meeder Asset Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2020, closing a stake of 50 shares — an estimated $3K sold.

Meeder Asset Management first reported a position in SRGA in Q4 2018 and held it in 6 quarters. The position peaked at $45K in Q2 2019. 88 funds tracked by Wall St. Rank hold SRGA as of Q2 2020.

  • Meeder Asset Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Meeder Asset Management sold 50 Surgalign Holdings, Inc. Common Stock shares in Q2 2020, an estimated $3K.
  • Meeder Asset Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q4 2018 and held it in 6 quarters.
  • Meeder Asset Management's Surgalign Holdings, Inc. Common Stock position peaked at $45K in Q2 2019.
  • 88 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2020.

Based on Meeder Asset Management's 13F filing for Q2 2020, filed 11 Aug 2020.